Trump announced his decision in a tweet following media reports that Kennedy would be his choice to lead the federal health ...

If you bring a baby into the Hurley Children’s Center clinic in downtown Flint, Michigan, Mona Hanna will find you. The ...

Michelle Peters Wellington announced Thursday that she has joined Vistagen Therapeutics as VP of communications. MM+M’s third ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

By registering you consent to the collection and use of your information to provide the products and services you have ...

Officials said they began distributing more than 2 million pieces of personal protective equipment in late May, four months ...

Vera Therapeutics appointed Amgen and Seagen alum Matt Skelton as EVP of commercial. Frank Lane was appointed SVP and head of ...

By leveling up their streaming campaigns, advertisers can achieve big lifts in awareness and sales of their medications among ...

As Merck prepares for its blockbuster immunotherapy Keytruda to face generic competition, it’s investing in a new cancer drug from LaNova.

BioNTech is investing in a promising space in oncology by acquiring Biotheus’ PD-L1 and VEGF bispecific antibody.

MM+M today debuted its 2025 Women of Distinction and Women to Watch award programs.

While HHS routinely imposes the death penalty on small operations, it has never barred a national Medicare supplier like ...